4.6 Article

Proviral Insertion in Murine Lymphomas 2 (PIM2) Oncogene Phosphorylates Pyruvate Kinase M2 (PKM2) and Promotes Glycolysis in Cancer Cells

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 49, Pages 35406-35416

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M113.508226

Keywords

Cancer; Cell Proliferation; Glycolysis; Phosphorylation; Pyruvate Kinase

Funding

  1. 973 Project [201203932604]
  2. New Drug Discovery Project [2012ZX09506-001-005]
  3. Shanghai Leading Academic Discipline Project [S30203]
  4. National Natural Science Foundation of China [81071180, 81001008, 81372195]
  5. Shanghai Pujiang Program [13PJ1406000]
  6. Science and Technology Commission of Shanghai Municipality [134119a5600]

Ask authors/readers for more resources

Pyruvate kinase M2 (PKM2) is a key player in the Warburg effect of cancer cells. However, the mechanisms of regulating PKM2 are not fully elucidated. Here, we identified the protein-serine/threonine kinase PIM2, a known oncogene, as a novel binding partner of PKM2. The interaction between PIM2 and PKM2 was confirmed by multiple biochemical approaches in vitro and in cultured cells. Importantly, we found that PIM2 could directly phosphorylate PKM2 on the Thr-454 residue, resulting in an increase of PKM2 protein levels. Compared with wild type, PKM2 with the phosphorylation-defective mutation displayed a reduced effect on glycolysis, co-activating HIF-1 and -catenin, and cell proliferation, while enhancing mitochondrial respiration of cancer cells. These findings demonstrate that PIM2-dependent phosphorylation of PKM2 is critical for regulating the Warburg effect in cancer, highlighting PIM2 as a potential therapeutic target.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available